
Georgia CTSA MSCR Graduate Leads Successful Study for Microbiota Treatments Addressing Antibiotic Resistance
Summary
Georgia CTSA Master of Science in Clinical Research (MSCR) graduate Dr. Michael Woodworth led a pioneering study demonstrating the safety and potential benefits of fecal microbiota transplantation to combat antibiotic-resistant bacteria in long-term care patients. His findings mark a promising advance in addressing “superbug” infections.
Article
Many patients in long-term acute care hospitals (LTACHs) have intestinal multidrug-resistant organism colonization. Despite risk for infection and transmission, no FDA-approved therapies exist to reduce it. To assess the safety and feasibility of fecal microbiota transplantation (FMT), Michael Woodworth, M.D., MSCR, Emory, led a non-randomized trial at a LTACH in Atlanta. Results showed FMT was well tolerated with no related serious adverse events.
https://georgiactsa.org/news-events/news/2025/discovery/woodworth-study/index.html



